#cardiovascular

Researchers reached this conclusion after reviewing data on more than 30,000 people.

A meta-analysis has helped clear up conflicting previous evidence regarding this association.

A study of veterans also found, as other studies have, that treating the virus helps mitigate the risk of cardiovascular disease.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

Direct-acting antivirals lower the risk of cardiovascular disease to a greater extent than interferon-based regimens.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Direct-acting antivirals lower this risk to a greater extent than interferon-based regimens.

A recent analysis of two studies of AbbVie’s hepatitis C regimen showed good results in this population.

Conditions such as autoimmune disorders, insulin resistance and cardiovascular disease tend to have a better outlook.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Conditions such as autoimmune disorders, insulin resistance and cardiovascular disease tend to have a better outlook.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

A look at the link between hepatitis C and heart disease.

Among the hep C population, other factors associated with chronic kidney disease include being older and having diabetes or HIV.